Anika Therapeutics (ANIK) Current Taxes (2011 - 2025)
Anika Therapeutics' (ANIK) quarterly Current Taxes came in at $65000.0 in Q1 2025, down 95.64% year-on-year from $1.5 million in Q1 2024, and up 3.17% on a QoQ basis from $63000.0 in Q4 2024.
Anika Therapeutics (ANIK) Current Taxes (2011 - 2025) Analysis & Trends
Anika Therapeutics (ANIK) has 13 years of Current Taxes data on file, last reported at $65000.0 in Q1 2025.
- On a quarterly basis, Current Taxes fell 95.64% year-over-year to $65000.0 in Q1 2025; TTM through Mar 2025 was $65000.0, a 95.64% decrease from a year earlier, with the FY2024 full-year figure at $63000.0, down 94.92% from the prior year.
- Current Taxes for Q1 2025 stood at $65000.0, up from $63000.0 in the prior quarter.
- Over the last five years, Current Taxes for ANIK reached as high as $1.5 million in Q1 2024 and fell as low as $63000.0 in Q4 2024.
- Historically, Current Taxes has averaged $646600.0 across 4 years, with a median of $814500.0 in 2022.
- Across the five-year window, Current Taxes soared 67.6% in 2024 and slumped 95.64% in 2025, its largest moves.
- Year by year, Current Taxes stood at $810000.0 in 2022, then surged by 53.09% to $1.2 million in 2023, then sank by 94.92% to $63000.0 in 2024, then advanced by 3.17% to $65000.0 in 2025.
- Per Business Quant data, the three most recent Current Taxes figures were $65000.0 in Q1 2025, $63000.0 in Q4 2024, and $82000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Anika Therapeutics | 198.50 Mn | 131.71 Mn | 19.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 819,000.00 |
| Jun 30, 2023 | 931,000.00 |
| Mar 31, 2023 | 889,000.00 |
| Dec 31, 2022 | 810,000.00 |
| Sep 30, 2019 | 766,000.00 |
| Jun 30, 2019 | 757,000.00 |
| Mar 31, 2019 | 1.30 Mn |
| Dec 31, 2018 | 385,000.00 |
| Jun 30, 2017 | 2.30 Mn |
| Sep 30, 2016 | 217,000.00 |
| Jun 30, 2016 | 591,000.00 |
| Mar 31, 2016 | 1.60 Mn |
| Dec 31, 2015 | 4.20 Mn |
| Sep 30, 2015 | 4.44 Mn |